Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 15, Issue 2, 2009, Pages 134-137

  Haensch, C A ^a   Lerch, H ^b   Jorg J ^a   Isenmann, S ^a  

^a HELIOS KLINIKUM WUPPERTAL   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Autonomic dysfunction; Cardiac denervation; MIBG SPECT; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMANTADINE; BENSERAZIDE; CARBIDOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; BREATHING RATE; CONTROLLED STUDY; FEMALE; HEART DENERVATION; HEART FUNCTION; HEART INNERVATION; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDING; SUPINE POSITION; TILT TABLE TEST; VALSALVA MANEUVER;

3-IODOBENZYLGUANIDINE; AUTONOMIC NERVOUS SYSTEM DISEASES; FEMALE; HEART; HEART RATE; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MYOCARDIAL PERFUSION IMAGING; PARKINSON DISEASE; RADIOPHARMACEUTICALS; SPECTRUM ANALYSIS; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 58549112580     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.04.031     Document Type: Article

References (23)

1. Magerkurth C., Schnitzer R., and Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res 15 2 (2005 Apr) 76-82
2. Goldstein D.S., Holmes C.S., Dendi R., Bruce S.R., and Li S.T. Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology 58 8 (2002 Apr 23) 1247-1255
3. Courbon F., Brefel-Courbon C., Thalamas C., Alibelli M.J., Berry I., Montastruc J.L., et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord 18 8 (2003 Aug) 890-897
4. Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 11 6 (2001 Dec) 351-355
5. Haensch C.-A., and Jörg J. Disturbed sympatho-vagal balance in heart rate variability as marker of progression in Parkinson's disease. J Neurol Sci 187 Suppl. 1 (2001) S133
6. Pursiainen V., Korpelainen J.T., Haapaniemi T.H., Sotaniemi K.A., and Myllyla V.V. Blood pressure and heart rate in parkinsonian patients with and without wearing-off. Eur J Neurol 14 4 (2007 Apr) 373-378
7. Kallio M., Haapaniemi T., Turkka J., Suominen K., Tolonen U., Sotaniemi K., et al. Heart rate variability in patients with untreated Parkinson's disease. Eur J Neurol 7 6 (2000 Nov) 667-672
8. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 55 3 (1992 Mar) 181-184
9. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 5 (1967 May) 427-442
10. Solanki K.K., Bomanji J., Moyes J., Mather S.J., Trainer P.J., and Britton K.E. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 13 7 (1992 Jul) 513-521
11. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93 5 (1996 Mar 1) 1043-1065
12. Novak V., Saul J.P., and Eckberg D.L. Task force report on heart rate variability. Circulation 96 3 (1997 Aug 5) 1056-1057
13. Haensch C.A., and Jorg J. Beat-to-beat blood pressure analysis after premature ventricular contraction indicates sensitive baroreceptor dysfunction in Parkinson's disease. Mov Disord 21 4 (2006 Apr) 486-491
14. Hishikawa N., Hashizume Y., Yoshida M., and Sobue G. Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol (Berl) 105 4 (2003 Apr) 341-350
15. Braak H., Bohl J.R., Muller C.M., Rub U., de Vos R.A., and Del Tredici K. Stanley Fahn lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 21 12 (2006 Dec) 2042-2051
16. Wolters E., and Braak H. Parkinson's disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70 (2006) 309-319
17. Matsui H., Udaka F., Oda M., Tamura A., Kubori T., Nishinaka K., et al. Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid. Ann Nucl Med 19 3 (2005 May) 225-229
18. Spiegel J., Hellwig D., Farmakis G., Jost W.H., Samnick S., Fassbender K., et al. Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease. Mov Disord 22 7 (2007 May 15) 1004-1008
19. Jellinger K.A. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14 3 (1991 Jun) 153-197
20. Braak H., Ghebremedhin E., Rub U., Bratzke H., and Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318 1 (2004 Oct) 121-134
21. Haensch C.A. Cardiac involvement in Parkinson's disease. In: Vespry A. (Ed). Cardiac arrhythmia research advances (2008), Nova Science Publishers, New York 217-230
22. Goldstein D.S., Holmes C., Li S.T., Bruce S., Metman L.V., and Cannon III R.O. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133 5 (2000 Sep 5) 338-347
23. Bonuccelli U., Lucetti C., Del Dotto P., Ceravolo R., Gambaccini G., Bernardini S., et al. Orthostatic hypotension in de novo Parkinson disease. Arch Neurol 60 10 (2003 Oct) 1400-1404